RESEARCH

Evidence before claims.

Clyra’s scientific work focuses on cross-species representation learning, comparative oncology, longitudinal tumor biology, and patient stratification for cancer drug development.

Clyra Perspectives

Technical Reports

External Evidence

Clyra Perspectives

Comparative Canine Oncology as an AI-enabled Accelerant for Human Cancer Drug Development

Comparative Canine Oncology as an AI-enabled Accelerant for Human Cancer Drug Development

A review of how naturally occurring canine cancers have contributed to human oncology programs and how cross-species AI could make comparative translation more systematic and scalable.

Read publication →

Independent research and external scientific precedent are presented for context and should not be interpreted as validation of Clyra’s platform performance.